There are recommendations for preventing these complications; for example, TPO-RA should be avoided in patients with acute ITP and COVID-19 due to the higher risk of thrombosis and hepatotoxicity [33]. The gene discussed is TPO; the disease is autoimmune thrombocytopenic purpura.